75. ESMO 2023 - Colorectal Cancer (Part 1)

Colorectal cancer remains the bread and butter of many an oncologist, but its commonality belies its complexity. In early and advanced disease alike, there remain many permutations, considerations and controversies regarding optimal treatment. What is the best way to treat potentially-resectable colorectal cancer with liver metastases (CRLM)? Is there a way to increase the responsiveness to immunotherapy in patients with proficient mismatch repair (pMMR)? And are we moving to a brighter future where patients with deficient MMR colorectal cancer could avoid surgical management through the miracle of immunotherapy? Ultimately, no one study is going to answer these questions, but with ESMO 2023, we may be starting to peel back the layers of this onion.

Studies discussed in today's episode (subscription may be required)

Please find us on Twitter @InquisitiveOnc!

Art courtesy of Taryn Silver

Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.